Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Bowcock
MA21.03 Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P3.01-76 Clinical Background and Response to Chemotherapy in NSCLC Patients With MET Exon14 Skipping Mutation or High MET Gene Copy Number
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Erratum to Combination MET- And EGFR-directed Therapy in MET-overexpressing Non-Small Cell Lung Cancers: Time to Move on to Better Biomarkers?
Translational Lung Cancer Research
Oncology
P3.01-60 a Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient With Acquired MET Amplification
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MET Targeted Therapy for Lung Cancer: Clinical Development and Future Directions
Lung Cancer: Targets and Therapy
Oncology
MET in Gastric Carcinomas: Comparison Between Protein Expression and Gene Copy Number and Impact on Clinical Outcome
British Journal of Cancer
Cancer Research
Oncology
OA12.01 Phase II Data for the MET Inhibitor Tepotinib in Patients With Advanced NSCLC and MET Exon 14-Skipping Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
HGF and C-Met in Pathogenesis of Endometrial Carcinoma
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Trends in the Development of MET Inhibitors for Hepatocellular Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition
PLoS ONE
Multidisciplinary